IndraLab
Statements
KRAS activates angiogenesis. 20 / 20
|
20
reach
"Given our hypothesis that IKKbeta promotes KRAS induced angiogenesis, which relies on KRAS induced VEGF and IL-8 secretion [XREF_BIBR, XREF_BIBR], and given that VEGF and IL-8 are transcriptional targets of NF-kappaB [XREF_BIBR], a transcription factor activated by oncogenic KRAS in the lung in an IKKbeta dependent manner [XREF_BIBR], we decided to investigate whether IKKbeta targeting would affect VEGF and IL-8 expression."
reach
"Taken together, these results provide a novel mechanistic understanding of how the IKKbeta pathway affects human lung tumorigenesis, indicating that IKKbeta promotes KRAS induced angiogenesis both by cancer cell-intrinsic and cancer cell independent mechanisms, which strongly suggests IKKbeta inhibition as a promising antiangiogenic approach to be explored for KRAS induced lung cancer therapy."
reach
"Similar results were obtained using another pair of immortalized human pancreatic duct derived cells, E6/E7/st and its oncogenic K-Ras variant, E6/E7/Ras/st. Taken together, our results suggest that angiogenesis is initiated by paracrine epithelial secretion of CXC chemokines and VEGF downstream of activated oncogenic K-Ras, and that this vascular maturation is in part dependent on MEK1/2 and c-Jun signaling."
reach
"PDAC often harbors the universal mutations in the proto-oncogene K-RAS (>90% prevalence in pancreatic cancer), which persistently accelerates and activates various oncogenic events (e.g., uncontrolled proliferation, sustained angiogenesis, metastasis, or invasion), thus leading to metabolic reprogramming and resistance to cell death [1, 2]."
reach
"GSEA identified a number of biological states and processes overrepresented in the glioblastoma infiltrating CD14 + cells relative to those in CD14 + blood cells, including signaling by KRAS, TGF-beta, and TNF-alpha; epithelial-mesenchymal transition; angiogenesis; coagulation; the G 2 / M cell cycle checkpoint; and hypoxia (XREF_FIG)."
reach
"Based on published studies showing that oncogenic RAS promotes angiogenesis by upregulating the proangiogenic NF-kappaB target genes IL-8 and VEGF, that NF-kappaB activation by KRAS requires the IKKbeta kinase, and that targeting IKKbeta reduces KRAS induced lung tumor growth in vivo, but has limited effects on cell growth in vitro, we hypothesized that IKKbeta targeting would reduce lung tumor growth by inhibiting KRAS induced angiogenesis."
reach
"Given that NF-kappaB activation by KRAS in the lung requires the IKKbeta kinase [XREF_BIBR], and that systemic IKKbeta targeting reduced KRAS induced lung tumor growth [XREF_BIBR], we hypothesized that IKKbeta, which is a druggable target in the KRAS induced NF-kappaB activation pathway, would be involved in mediating KRAS induced angiogenesis."
reach
"Taken together, our results indicate that IKKbeta promotes KRAS induced angiogenesis by both cancer cell-intrinsic and cancer cell independent mechanisms, which strongly suggests IKKbeta inhibition as a promising antiangiogenic approach to be explored for KRAS induced lung cancer therapy and possibly also for therapy of other KRAS driven malignancies."